Panchsheel Organics Ltd
Incorporated in 1990, Panchsheel Organics Ltd is a manufacturer of Bulk Drug and Intermediate[1]
- Market Cap ₹ 238 Cr.
- Current Price ₹ 202
- High / Low ₹ 226 / 160
- Stock P/E 16.6
- Book Value ₹ 86.8
- Dividend Yield 1.68 %
- ROCE 26.7 %
- ROE 20.5 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
- Company has delivered good profit growth of 30.8% CAGR over last 5 years
Cons
- Promoter holding has decreased over last quarter: -1.96%
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Bulk Drugs
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
29 | 33 | 39 | 36 | 40 | 40 | 42 | 48 | 50 | 49 | 69 | 103 | 103 | |
26 | 29 | 35 | 31 | 34 | 33 | 35 | 41 | 42 | 41 | 56 | 83 | 85 | |
Operating Profit | 3 | 3 | 4 | 5 | 6 | 7 | 7 | 7 | 9 | 9 | 13 | 20 | 18 |
OPM % | 11% | 10% | 11% | 13% | 14% | 17% | 16% | 14% | 17% | 18% | 19% | 19% | 18% |
0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 4 | |
Interest | 1 | 1 | 1 | 1 | 1 | 0 | 1 | 0 | 0 | 0 | 0 | 1 | 0 |
Depreciation | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 | 2 |
Profit before tax | 3 | 2 | 3 | 3 | 4 | 5 | 5 | 6 | 7 | 7 | 11 | 19 | 19 |
Tax % | 30% | 28% | 35% | 32% | 27% | 36% | 29% | 29% | 28% | 31% | 27% | 26% | |
2 | 1 | 2 | 2 | 3 | 3 | 4 | 4 | 5 | 5 | 8 | 14 | 14 | |
EPS in Rs | 1.82 | 1.27 | 1.76 | 1.90 | 3.04 | 3.21 | 3.67 | 4.04 | 5.29 | 5.01 | 8.33 | 11.94 | 12.17 |
Dividend Payout % | 0% | 20% | 14% | 13% | 17% | 16% | 14% | 12% | 0% | 20% | 18% | 7% |
Compounded Sales Growth | |
---|---|
10 Years: | 12% |
5 Years: | 20% |
3 Years: | 27% |
TTM: | 7% |
Compounded Profit Growth | |
---|---|
10 Years: | 27% |
5 Years: | 31% |
3 Years: | 39% |
TTM: | 2% |
Stock Price CAGR | |
---|---|
10 Years: | 33% |
5 Years: | 42% |
3 Years: | 68% |
1 Year: | 2% |
Return on Equity | |
---|---|
10 Years: | 16% |
5 Years: | 17% |
3 Years: | 18% |
Last Year: | 21% |
Balance Sheet
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Sep 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Equity Capital | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 5 | 10 | 12 | 12 |
Reserves | 11 | 11 | 12 | 13 | 16 | 19 | 22 | 25 | 30 | 35 | 37 | 78 | 90 |
5 | 6 | 5 | 7 | 5 | 7 | 6 | 5 | 4 | 4 | 4 | 6 | 6 | |
9 | 10 | 12 | 8 | 11 | 9 | 12 | 9 | 12 | 14 | 22 | 27 | 29 | |
Total Liabilities | 30 | 32 | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 137 |
8 | 8 | 8 | 7 | 7 | 8 | 7 | 7 | 6 | 7 | 7 | 8 | 8 | |
CWIP | 0 | 0 | 0 | 0 | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 4 | 4 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 3 |
22 | 24 | 28 | 26 | 28 | 30 | 36 | 36 | 44 | 49 | 65 | 111 | 122 | |
Total Assets | 30 | 32 | 35 | 33 | 37 | 39 | 44 | 44 | 52 | 58 | 74 | 123 | 137 |
Cash Flows
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 1 | 3 | 1 | 3 | 1 | 3 | 2 | 5 | 5 | -2 | 0 | |
-0 | -1 | -1 | -1 | -2 | -2 | -1 | -1 | -2 | -1 | -0 | -34 | |
-2 | 0 | -2 | 0 | -1 | 1 | -2 | -2 | -1 | -2 | -1 | 36 | |
Net Cash Flow | -1 | 0 | 0 | 0 | -1 | 0 | -0 | 0 | 1 | 3 | -2 | 1 |
Ratios
Figures in Rs. Crores
Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Debtor Days | 131 | 134 | 130 | 142 | 134 | 138 | 170 | 137 | 164 | 140 | 172 | 137 |
Inventory Days | 142 | 142 | 124 | 154 | 155 | 185 | 185 | 164 | 186 | 246 | 237 | 181 |
Days Payable | 111 | 103 | 108 | 80 | 109 | 83 | 124 | 73 | 111 | 152 | 158 | 89 |
Cash Conversion Cycle | 162 | 174 | 146 | 216 | 181 | 240 | 231 | 229 | 239 | 235 | 251 | 230 |
Working Capital Days | 175 | 173 | 145 | 179 | 155 | 184 | 190 | 189 | 200 | 187 | 208 | 190 |
ROCE % | 15% | 11% | 15% | 14% | 19% | 20% | 18% | 18% | 20% | 19% | 25% | 27% |
Documents
Announcements
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 2d
- Announcement under Regulation 30 (LODR)-Resignation of Company Secretary / Compliance Officer 29 Mar
- Closure of Trading Window 29 Mar
-
Announcement under Regulation 30 (LODR)-Allotment
7 Mar - Conversion of convertible warrant into equity shares on preferential basis
- Board Meeting Outcome for Approved The Proposal To Acquire A Factory Premises. 28 Feb
Annual reports
-
Financial Year 2023
from bse
-
Financial Year 2022
from bse
-
Financial Year 2021
from bse
-
Financial Year 2020
from bse
-
Financial Year 2019
from bse
-
Financial Year 2018
from bse
-
Financial Year 2017
from bse
-
Financial Year 2016
from bse
-
Financial Year 2015
from bse
-
Financial Year 2014
from bse
-
Financial Year 2013
from bse
-
Financial Year 2012
from bse
-
Financial Year 2011
from bse
-
Financial Year 2010
from bse
-
Financial Year 2009
from bse
Business Overview:[1]
POL is a part of Turakhia Bros group. It is a WHO Compliant, ISO and GMP certified manufacturer and exporter of a range of APIs, Intermediates, Nutraceutical, Vitamins Hormones, Steroids, Finished Formulations (Human & Veterinary), Agri Biotech range (Bio Fertilizers, Bio Stimulants,Growth Promoters), Aqua Culture, Dehydrated Culture Media